Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Quality Control: SOP for Reviewing QC Test Results before Product Release – V 2.0

Posted on By

Quality Control: SOP for Reviewing QC Test Results before Product Release – V 2.0

Standard Operating Procedure for Reviewing QC Test Results before Product Release in Injectable Manufacturing


Department Quality Control
SOP No. SOP/QC/183/2025
Supersedes SOP/QC/183/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To establish a systematic procedure for reviewing Quality Control (QC) test results before releasing batches of injectable pharmaceutical products. This ensures that products meet defined specifications and comply with current

Good Manufacturing Practices (cGMP), WHO, and ICH guidelines before batch disposition.

2. Scope

This SOP applies to all personnel involved in the review of QC analytical results for raw materials, in-process samples, and finished injectable products manufactured at the facility.

3. Responsibilities

  • QC Analyst: Performs analysis and documents results in test reports and laboratory notebooks.
  • QC Reviewer: Conducts second-level review of data, calculations, and compliance with SOPs.
  • QA Officer: Verifies test results against product specifications and reviews for GMP compliance.
  • Head QC: Final reviewer and approver of QC documents before batch release.
See also  Sterile Injectable Manufacturing: SOP for Documentation of Dispensed Quantities - V 2.0

4. Accountability

The Head of Quality Control is accountable for ensuring the integrity, accuracy, and completeness of all QC test results prior to product release.

5. Procedure

5.1 Collection and Compilation of Test Results

  1. All QC testing must be conducted using validated methods as per the approved specifications.
  2. Analysts shall compile the raw data, chromatograms, calculation sheets, instrument printouts, and test reports in a designated folder labeled with batch number (Annexure-1).

5.2 First-Level Review by QC Reviewer

  1. The assigned reviewer shall:
    • Cross-check analytical calculations and results
    • Verify chromatogram integration and peak identification
    • Ensure compliance with the standard method of analysis
    • Confirm instrument calibration and environmental log entries
  2. In case of discrepancies or missing data, the folder shall be returned to the analyst for correction or justification.

5.3 Comparison with Approved Specifications

  1. The reviewer shall compare each result with respective product specifications including:
    • Assay (potency)
    • pH, Osmolality
    • Particulate matter
    • Endotoxin and Sterility
    • Impurity profile and residual solvent limits
  2. Record the final results in the Finished Product Specification Summary Sheet (Annexure-2).
See also  Sterile Injectable Manufacturing: SOP for Osmolality Testing of Injectable Products - V 2.0

5.4 Review of OOS, OOT, and Deviations

  1. If any Out-of-Specification (OOS) or Out-of-Trend (OOT) result is observed:
    • Verify if it has been previously investigated
    • Ensure proper documentation and CAPA were implemented

5.5 QA Review and Approval

  1. QC results folder is sent to QA for a second-level review.
  2. QA verifies:
    • QC Reviewer’s sign-off
    • Completeness of documents
    • Test compliance with specifications
  3. Once approved, QA stamps the “Approved for Release” status on the QC Report (Annexure-3).

5.6 Archival

  1. All test results shall be scanned and saved electronically on the secure QA drive with backup maintained.
  2. Hard copies shall be filed batch-wise and retained as per company record retention policy.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • OOS: Out of Specification
  • OOT: Out of Trend
  • GMP: Good Manufacturing Practice

7. Documents

  1. QC Data Folder Checklist – Annexure-1
  2. Specification Summary Sheet – Annexure-2
  3. QC Report Approval Form – Annexure-3
See also  Sterile Injectable Manufacturing: SOP for Labeling of Dispensed Materials - V 2.0

8. References

  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria
  • WHO GMP Guidelines for Pharmaceuticals
  • 21 CFR Part 211 Subpart I – Laboratory Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Executive QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance

11. Annexures

Annexure-1: QC Data Folder Checklist

Item Available Remarks
Chromatograms Yes All attached
Calculations Yes Verified
Raw Data Yes Signed
Specifications Yes Current version used

Annexure-2: Specification Summary Sheet

Test Result Specification Complies
Assay 98.7% 90-110% Yes
pH 6.5 5.5–7.0 Yes
Particulate Matter Complies NMT 6000 particles ≥ 10µm Yes

Annexure-3: QC Report Approval Form

Batch No. IVX2204
Product Injexol 100mg
QC Reviewer Sunita Reddy
QA Reviewer Rajesh Kumar
Release Status Approved for Release

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Updated review steps and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Essential SOPs for Regulatory Inspection Readiness in Pharma
Next Post: Analytical Method Development: SOP for Viscosity Method Development Using Brookfield Viscometer – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version